We hope that our research widens the current understanding of the role of M2-like TAMs in the biology of melanoma and prognosis prediction and that VARS1 can be a novel predictive biomarker of clinical outcome and immunotherapy response in melanoma. Here, VARS1 is linked to melanoma.